Filing Details

Accession Number:
0000899243-19-027290
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-14 17:00:59
Reporting Period:
2019-11-12
Accepted Time:
2019-11-14 17:00:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX Pharmaceutical Preparations (2834) 461454898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700717 Clarus Iv-D, L.p. C/O Clarus Ventures
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1700718 Clarus Iv-C, L.p. C/O Clarus Ventures
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1700719 Clarus Iv-B, L.p. C/O Clarus Ventures
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1700720 Clarus Iv-A, L.p. C/O Clarus Ventures
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1793305 L.p. Gp Iv Clarus C/O Clarus Ventures
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-12 461,769 $0.00 461,769 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 301,001 $0.00 301,001 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 555,193 $0.00 555,193 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 111,021 $0.00 111,021 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 80,786 $12.00 542,555 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 52,660 $12.00 353,661 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 97,131 $12.00 652,324 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2019-11-12 19,423 $12.00 130,444 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnotes
No 4 C Indirect See Footnotes
No 4 C Indirect See Footnotes
No 4 C Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Redeemable Convertible Preferred Stock Disposition 2019-11-12 2,334,966 $0.00 461,769 $0.00
Common Stock Series C Redeemable Convertible Preferred Stock Disposition 2019-11-12 1,552,035 $0.00 301,001 $0.00
Common Stock Series C Redeemable Convertible Preferred Stock Disposition 2019-11-12 2,807,372 $0.00 555,193 $0.00
Common Stock Series C Redeemable Convertible Preferred Stock Disposition 2019-11-12 561,385 $0.00 111,021 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. These shares of the Issuer's Series C redeemable convertible preferred stock ("Redeemable Convertible Preferred Stock") are convertible into shares of the Issuer's common stock ("Common Stock") on a 0.197763-for-one basis at the holder's election and have no expiration date. The Redeemable Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering.
  2. These securities are held directly by Clarus IV-A, L.P.
  3. These securities are held directly by Clarus IV-B, L.P.
  4. These securities are held directly by Clarus IV-C, L.P.
  5. These securities are held directly by Clarus IV-D, L.P. (collectively, with Clarus IV-A, L.P., Clarus IV-B, L.P. and Clarus IV-C, L.P., the "Clarus Funds").
  6. The general partner of each of the Clarus Funds is Clarus IV GP, L.P. The general partner of Clarus IV GP, L.P. is Blackstone Clarus GP L.P. The general partner of Blackstone Clarus GP L.P. is Blackstone Clarus GP L.L.C. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings II L.P. The general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Class C common stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
  7. Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4.
  8. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
  9. Each of such Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the Clarus Funds to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.